Artal Group’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$7.75M Hold
2023
Q2
$12M Hold
2023
Q1
$12.8M Buy
2019
Q2
Sell
2019
Q1
$1.4M Hold
2018
Q4
$1.51M Hold
2018
Q3
$2.79M Hold
2018
Q2
$3.21M Hold
2018
Q1
$3.5M Buy
2017
Q4
$1.04M Hold
2017
Q3
$915K Buy